XML 104 R37.htm IDEA: XBRL DOCUMENT v3.25.2

Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

			Three Months Ended June 30,												Six Months Ended June 30,
			2025						2024						2025						2024
Revenue			$	70					$	—					$	70					$	—
Operating Expenses:
Research and development by significant expense:
BOLSTER trial			605						1,075						1,393						2,345
ASCEND trial			32						94						53						138
Chemistry, manufacturing and controls			167						284						387						939
Clinical department			991						1,056						2,148						2,190
Other (1)			458						92						875						230
Research and development			2,253						2,601						4,856						5,842
General and administrative by significant expense:
Corporate			1,157						1,272						2,302						2,404
Investor relations/public relations/communications			309						347						640						632
Finance			538						585						1,167						1,165
Legal			327						239						551						909
Business development			140						145						267						317
Share based compensation expense			212						200						616						568
Other (2)			2						134						387						287
General and administrative			2,685						2,922						5,930						6,282
Operating loss			(4,868)						(5,523)						(10,716)						(12,124)
Other income, net			209						479						371						881
Benefit from income taxes			—						—						(962)						(798)
Net loss			$	(4,659)					$	(5,044)					$	(9,383)					$	(10,445)
Cash and marketable securities															$	21,970					$	38,262
(1) Included in Other are the GBM study,      FORTIFIDE study and research oncology      expenses
(2) Included in Other are facilities expense, human      resource and information technology expenses

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration